Titre : Arcade dentaire

Arcade dentaire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cyclooxygenase 2
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Arcade dentaire : Questions médicales les plus fréquentes", "headline": "Arcade dentaire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Arcade dentaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-31", "dateModified": "2025-04-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Arcade dentaire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Mâchoire", "url": "https://questionsmedicales.fr/mesh/D007568", "about": { "@type": "MedicalCondition", "name": "Mâchoire", "code": { "@type": "MedicalCode", "code": "D007568", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A14.521" } } }, "about": { "@type": "MedicalCondition", "name": "Arcade dentaire", "alternateName": "Dental Arch", "code": { "@type": "MedicalCode", "code": "D003724", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mohammed Nahidh", "url": "https://questionsmedicales.fr/author/Mohammed%20Nahidh", "affiliation": { "@type": "Organization", "name": "Department of Orthodontics, College of Dentistry, University of Baghdad, 10001 Baghdad, Iraq." } }, { "@type": "Person", "name": "Birgit Marré", "url": "https://questionsmedicales.fr/author/Birgit%20Marr%C3%A9", "affiliation": { "@type": "Organization", "name": "Department of Prosthetic Dentistry, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany." } }, { "@type": "Person", "name": "Angelika Rauch", "url": "https://questionsmedicales.fr/author/Angelika%20Rauch", "affiliation": { "@type": "Organization", "name": "Department of Prosthodontics and Materials Science, University of Leipzig, Leipzig, Germany." } }, { "@type": "Person", "name": "Torsten Mundt", "url": "https://questionsmedicales.fr/author/Torsten%20Mundt", "affiliation": { "@type": "Organization", "name": "Department of Prosthodontics, Gerodontology and Biomaterials, Dental School, University of Greifswald, Greifswald, Germany." } }, { "@type": "Person", "name": "Wolfgang Hannak", "url": "https://questionsmedicales.fr/author/Wolfgang%20Hannak", "affiliation": { "@type": "Organization", "name": "Department of Prosthodontics, Geriatic Dentistry and Craniomandibular Disorders, Center for Dental and Craniofacial Sciences, Charité - Universitätsmedizin Berlin CC3 - Charité, Berlin, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Design, synthesis, and biological evaluation of new celecoxib analogs as apoptosis inducers and cyclooxygenase-2 inhibitors.", "datePublished": "2022-08-17", "url": "https://questionsmedicales.fr/article/35976138", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/ardp.202200190" } }, { "@type": "ScholarlyArticle", "name": "Cyclooxygenase Inhibitors and Cancer: The Missing Pieces.", "datePublished": "2023-06-06", "url": "https://questionsmedicales.fr/article/37280092", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1124/jpet.122.001631" } }, { "@type": "ScholarlyArticle", "name": "Acyl-quinic acids from the root bark of Acanthopanax gracilistylus and their inhibitory effects on neutrophil elastase and cyclooxygenase-2 in vitro.", "datePublished": "2023-08-21", "url": "https://questionsmedicales.fr/article/37634270", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.bioorg.2023.106798" } }, { "@type": "ScholarlyArticle", "name": "Targeted isolation of cyclooxygenase-2 inhibitors from Saussurea obvallata using affinity ultrafiltration combined with preparative liquid chromatography.", "datePublished": "2023-01-27", "url": "https://questionsmedicales.fr/article/36773385", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jchromb.2023.123620" } }, { "@type": "ScholarlyArticle", "name": "Risk factor management matters more than pharmaceutical cyclooxygenase-2 inhibition in the prevention of de novo intracranial aneurysms.", "datePublished": "2022-06-27", "url": "https://questionsmedicales.fr/article/35678735", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ene.15442" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Système stomatognathique", "item": "https://questionsmedicales.fr/mesh/D013284" }, { "@type": "ListItem", "position": 3, "name": "Mâchoire", "item": "https://questionsmedicales.fr/mesh/D007568" }, { "@type": "ListItem", "position": 4, "name": "Arcade dentaire", "item": "https://questionsmedicales.fr/mesh/D003724" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Arcade dentaire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Arcade dentaire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Général", "headline": "Général sur Arcade dentaire", "description": "Erreur lors de la génération.", "url": "https://questionsmedicales.fr/mesh/D003724?mesh_terms=Cyclooxygenase+2&page=2#section-général" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Erreur lors de la génération.", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Veuillez réessayer ultérieurement." } } ] } ] }

Sources (10000 au total)

Acyl-quinic acids from the root bark of Acanthopanax gracilistylus and their inhibitory effects on neutrophil elastase and cyclooxygenase-2 in vitro.

Eleven new acyl-quinic acids (AQAs) 1a-9, and 18 known AQAs 10-27 were isolated from the root bark of Acanthopanax gracilistylus W. W. Smith (Acanthopanacis Cortex). The planar structures of 1a-9 were...

Targeted isolation of cyclooxygenase-2 inhibitors from Saussurea obvallata using affinity ultrafiltration combined with preparative liquid chromatography.

Saussurea obvallata (S. obvallata) is widely used in Qinghai-Tibet Plateau with high medicinal and edible values of reducing inflammation. But, the individual components and mechanisms of action still...

Risk factor management matters more than pharmaceutical cyclooxygenase-2 inhibition in the prevention of de novo intracranial aneurysms.

Pathophysiological studies of saccular intracranial aneurysm (sIA) disease have shown that inflammation plays a crucial role in sIA development. Pharmaceutical inhibition of COX-2-PGE2-NF-κB signaling... The impact of COX-2 inhibition on de novo sIA formation was studied in two cohorts: in a previously described angiographically followed cohort of 1419 sIA patients and in a cohort of 117 sIA patients ... De novo sIA patients were younger and more often smokers. Use of COX-2 selective inhibitors or nonsteroidal anti-inflammatory drugs did not significantly reduce de novo sIA formation, but the percenta... For the prevention of de novo sIA formation, risk factor management with focus on cessation of smoking and treating hypertension adequately seems more important than pharmaceutical COX-2 inhibition....

Proliferative Diabetic Retinopathy Microenvironment Drives Microglial Polarization and Promotes Angiogenesis and Fibrosis via Cyclooxygenase-2/Prostaglandin E2 Signaling.

Diabetic retinopathy (DR) is the leading cause of visual impairment, particularly in the proliferative form (proliferative DR [PDR]). The impact of the PDR microenvironment on microglia, which are the...